A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Clinical trial NCT06091865 · RECRUITING
Trial details
- NCT number
- NCT06091865
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-13
- Primary completion
- 2028-03-30
- Enrollment
- 904
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.